SCHEMBL30183301

SCHEMBL30183301

CC1(C)Cc2cnc(N)nc2-c2[nH]nc(C(=O)Nc3nc(C(=O)N4CCC(N5CCCCC5)CC4)cs3)c21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPC3 Q13507 5/20 0.36
TRPC6 Q9Y210 5/20 0.36
ATR Q13535 2/20 0.35
TSHR P16473 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
L3MBTL3 Q96JM7 1/20 0.33
RAB9A P51151 2/20 0.33
CCNK O75909 1/20 0.33
CDK12 Q9NYV4 1/20 0.33
PIM1 P11309 1/20 0.33
PIM3 Q86V86 1/20 0.33
LRRK2 Q5S007 1/20 0.32
MAPKAPK2 P49137 1/20 0.32
F2 P00734 1/20 0.32
F10 P00742 1/20 0.32
NPC1 O15118 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
ALOX15 P16050 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20649200 1.00 TRPC3 (0.36) TRPC3TRPC6ATRTSHRL3MBTL1
SCHEMBL20649319 0.89 F2 (0.45) ATRF2F10ALDH1A1
SCHEMBL30183940 0.89 F2 (0.45) ATRF2F10ALDH1A1
SCHEMBL30183178 0.89 F2 (0.45) ATRF2F10ALDH1A1
SCHEMBL20649396 0.89 F2 (0.45) ATRF2F10ALDH1A1
SCHEMBL20649285 0.88 ATR (0.36) ATRL3MBTL1L3MBTL3RAB9ALRRK2
SCHEMBL30183031 0.88 ATR (0.36) ATRL3MBTL1L3MBTL3RAB9ALRRK2
SCHEMBL20649145 0.88 ATR (0.31) ATRF2F10
SCHEMBL30183497 0.88 ATR (0.31) ATRF2F10
SCHEMBL20649192 0.88 F2 (0.46) ATRF2F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110997678-B Pyrazoloquinazoline derivatives as choline kinase inhibitors 内尔维亚诺医疗科学公司 2023-02-21 CN claimed
CN-110997678-B Pyrazoloquinazoline derivatives as choline kinase inhibitors 内尔维亚诺医疗科学公司 2023-02-21 CN disclosed